Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.
about
Microbiota regulate intestinal epithelial gene expression by suppressing the transcription factor Hepatocyte nuclear factor 4 alphaNLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth.Dietary Protein and Amino Acid Supplementation in Inflammatory Bowel Disease Course: What Impact on the Colonic Mucosa?High Demand for Psychotherapy in Patients with Inflammatory Bowel Disease.Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition.MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation.Novel insights into microbiome in colitis and colorectal cancer.The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon.P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers.Characteristics of Fecal Microbiota in Pediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.Guiding longitudinal sampling in IBD cohorts.Gut microbiota in the pathogenesis of inflammatory bowel disease.Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice.Interactions between diet and the intestinal microbiota alter intestinal permeability and colitis severity in mice.Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease.Sentinels at the frontline: the role of intraepithelial lymphocytes in inflammatory bowel disease.The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis.Oral Escherichia coli expressing IL-35 meliorates experimental colitis in mice.Obstructive Lymphangitis Precedes Colitis in Murine Norovirus-Infected Stat1-Deficient Mice.Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn's Disease Patients.Roseburia intestinalis inhibits interleukin‑17 excretion and promotes regulatory T cells differentiation in colitis.High carriage of adherent invasive E. coli in wildlife and healthy individuals.5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis.The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel DiseaseIntestinal bacterial biofilms modulate mucosal immune responsesInter-kingdom effect on epithelial cells of the N-Acyl homoserine lactone 3-oxo-C12:2, a major quorum-sensing molecule from gut microbiotaFecal Microbiota Transplantation Ameliorates Experimentally Induced Colitis in Mice by Upregulating AhRGut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infectionVariability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patientsUric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease: A reappraisal of the role of S. cerevisiae in this settingMicrobiota-sensitive epigenetic signature predicts inflammation in Crohn's disease
P2860
Q33865173-42511461-0FC7-4DDE-B0EC-1CE88C4C6B29Q36306103-BC897E15-A758-48D6-8900-CD149F6EA4F6Q36320785-51FA863F-C5D3-447D-A8DF-770AE0450BF0Q38620028-64685714-4671-41EA-84B7-AA810BD19644Q38650504-ACA7597A-5FF3-49F9-B172-7D5164FA4876Q38840924-433CE832-1B9C-48B6-AF3F-D389F9206DA4Q40064558-B419D317-850B-45BA-A05B-616A06D2B268Q40098403-BF7D055B-A508-4E7F-B138-08DA8BE126D6Q42317765-29854524-E92C-479D-802C-F1F93C8A4674Q46250258-170EF7F9-CDA8-4769-909D-79E2EA23C964Q46791659-7D5635F0-61E9-4505-9FFB-EC0F0AD8DC6FQ47236027-B12A3ACE-6C16-4E02-9BD5-1636DD6B1B80Q47258530-3E45D8FF-59C9-429F-B669-E7F68FB5AB70Q47309165-DE584531-4805-4F26-9AF3-1D4EF033BA10Q47365730-8D6AFD66-DD7B-49CE-8E30-ABADEE6275F0Q47742865-C822D5D6-B504-4C10-A399-179DF369AF85Q47818880-982572B3-B7B6-41F1-90B9-121D2927B292Q49622550-399CF49C-5457-471F-A4F5-BEE2453333AEQ49834319-1FFDD11E-2A2A-403F-8C58-45BCE8440CBEQ50699253-B3968A51-3A15-4E76-9B12-7C7F14B5299BQ52648353-EA64B49F-7D4C-4CC8-B956-4B5FAB295538Q54213681-1A2FE56A-2FB1-4E74-9C13-26D1EAE4D658Q55026569-2943C948-A2F3-4ACE-9F3C-5FEB84276D52Q55128199-DFF177F7-2942-46FE-9883-1D7A54E49F0AQ55305058-8804A576-8973-4AE3-B4C8-FCBD159F9894Q55462963-04E55B3E-EB8C-49CC-91E7-273525D1359AQ57492072-E96FB0F2-8AB8-4968-AB5C-27D8B3C20828Q58581113-22295C00-F589-43FA-9E51-5E9B209B6E38Q58696113-9B6D5E21-FC3B-444F-B335-A5BBDE8D9EF4Q58705341-AC34732A-E618-4038-871A-DB940C312EB9Q58756108-93DC6A5E-01A9-442E-9F13-33352B781778Q58787245-304D14FA-287C-4480-977C-750F1B61E4E9Q58795687-A18B395A-D0DB-4C84-B303-2A468B7CA99BQ59125547-5BBCD809-16C2-4B1C-A8D0-11173B316BD4
P2860
Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Roles for Intestinal Bacteria, ...... es and Therapeutic Approaches.
@ast
Roles for Intestinal Bacteria, ...... es and Therapeutic Approaches.
@en
type
label
Roles for Intestinal Bacteria, ...... es and Therapeutic Approaches.
@ast
Roles for Intestinal Bacteria, ...... es and Therapeutic Approaches.
@en
prefLabel
Roles for Intestinal Bacteria, ...... es and Therapeutic Approaches.
@ast
Roles for Intestinal Bacteria, ...... es and Therapeutic Approaches.
@en
P2860
P1433
P1476
Roles for Intestinal Bacteria, ...... es and Therapeutic Approaches.
@en
P2093
R Balfour Sartor
P2860
P304
327-339.e4
P356
10.1053/J.GASTRO.2016.10.012
P407
P577
2016-10-18T00:00:00Z